Us Bancorp \De\ Akouos, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.65 - $11.38 $14,726 - $21,906	-1,925 Reduced 79.38%	500 $4,000
Q3 2021 Nov 10, 2021	BUY	$9.93 - $13.59 $3,713 - $5,082	374 Added 18.24%	2,425 $28,000
Q2 2021 Aug 05, 2021	BUY	$11.87 - $15.96 $6,540 - $8,793	551 Added 36.73%	2,051 $26,000
Q1 2021 Apr 28, 2021	BUY	$13.87 - $21.04 $20,805 - $31,560	1,500 New	1,500 $21,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.